AIDSVax: Phase III trials update

VaxGen Inc. (VXGN), Brisbane, Calif.
Product: AIDSVax
Business: Infectious diseases
Therapeutic category: Immune stimulation
Target:

Read the full 156 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE